OverT Bio, an NYC-based cell therapy company, has been awarded a $120,000 G-Rex Grant from ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady. This grant will support OverT Bio’s ongoing development efforts, which will lead to next-generation cell therapies for solid tumors based on the data-driven discovery platforms OverTarget and OverTCR.   The G-Rex Grant is part of ScaleReady’s $20 million grant program aimed at advancing Cell and Gene...